New York & Company (NYSE: NWY) reported earnings on Nov. 28. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Oct. 27 (Q3), New York & Company beat slightly on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue grew slightly and GAAP loss per share dropped.

Margins grew across the board.

Revenue details
 New York & Company recorded revenue of $219.3 million. The seven analysts polled by S&P Capital IQ expected revenue of $215.5 million on the same basis. GAAP reported sales were 1.2% higher than the prior-year quarter's $216.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at -$0.06. The five earnings estimates compiled by S&P Capital IQ anticipated -$0.07 per share. GAAP EPS were -$0.06 for Q3 compared to -$0.15 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 27.8%, 310 basis points better than the prior-year quarter. Operating margin was -1.7%, 110 basis points better than the prior-year quarter. Net margin was -1.8%, 230 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $278.8 million. On the bottom line, the average EPS estimate is $0.08.

Next year's average estimate for revenue is $949.8 million. The average EPS estimate is -$0.06.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 300 members out of 348 rating the stock outperform, and 48 members rating it underperform. Among 105 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 93 give New York & Company a green thumbs-up, and 12 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on New York & Company is outperform, with an average price target of $4.47.